Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Lung Cancer

Alecensa a New First-Line Treatment for Lung Cancer with ALK Mutation
In November 2017, the FDA approved Alecensa for the treatment of all patients with metastatic non–small-cell lung cancer (NSCLC) and ALK mutation. Read More ›

3 Questions to Ask When Being Diagnosed with Lung Cancer
Dr. Bruce Gershenhorn explores 3 questions patients should ask after learning they have lung cancer. Knowledge is power. Read More ›

Important Changes in Lung Cancer Therapy Reported at ESMO 2017
Significant developments in the treatment of lung cancer were reported at the 2017 annual meeting of the European Society for Medical Oncology (ESMO) in Madrid, Spain. Read More ›

5 Things You Need to Know About Low-Dose CT Screening for Lung Cancer
Low-dose CT screening is the only screening method recommended by the US Preventive Services Task Force for lung cancer, yet only 3.9% of eligible people are actually screened. Read More ›

Immunotherapy Drugs Extend Survival of Patients with Lung Cancer
Check out some of the most exciting immunotherapies that are giving hope to people fighting this disease, which is responsible for 1 in every 4 cancer-related deaths in the United States. Read More ›

Lung Cancer Survivor: I Won’t Let Cancer Define Me
Read Melissa Crouse’s resilient story of survival, as she deals with the surprising diagnosis of lung cancer as a nonsmoker. Read More ›

 Prevention Strategies in the Fight Against Lung Cancer
Prevention is an integral part of life. Since lung cancer causes more deaths than any other type of cancer, taking steps to prevent this deadly disease should be a “no-brainer.” Read More ›

A Young Athlete, Never-Smoker, and a Lung Cancer Survivor
This is Taylor Duck's story of being diagnosed with lung cancer as a never-smoker. Read More ›

Immunotherapies for Patients with Lung Cancer
Lung cancer is the leading cause of cancer-related deaths in the United States. According to the American Cancer Society, approximately 224,390 people will be diagnosed with lung cancer in 2016, and more than 158,000 patients will die from this disease. Smoking is the major risk factor for lung cancer–80% of lung cancer deaths are related to smoking. Read More ›

Triathlete, Nonsmoker, and a Lung Cancer Diagnosis: Kirk Smith's Quest to Empower Cancer Research & Patient Self-Education
It’s hard to believe that Kirk Smith, the 54-year-old owner of an advertising company, a triathlete, and a runner for the past 15 years or so, has lung cancer. Read More ›

Page 11 of 12